| Segment Reporting |
The following table reflects results of operations of the Company’s reportable segment (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Infusion services net revenue | $ | 1,416,777 | | | $ | 1,393,008 | | | $ | 2,742,784 | | | $ | 2,704,189 | | | Other revenue (1) | 25,623 | | | 23,077 | | | 50,270 | | | 44,868 | | | Total Option Care Health revenue | 1,442,400 | | | 1,416,085 | | | 2,793,054 | | | 2,749,057 | | | (Expense) Income: | | | | | | | | | Cost of net revenues - drugs | (1,024,241) | | | (1,004,610) | | | (1,973,605) | | | (1,937,678) | | | Salaries, benefits, and other employee expense | (213,631) | | | (212,195) | | | (430,224) | | | (417,887) | | | Other segment items (2) | (101,936) | | | (100,329) | | | (199,181) | | | (199,607) | | | Depreciation and amortization expense | (17,452) | | | (16,241) | | | (32,359) | | | (31,987) | | | Interest expense, net | (14,020) | | | (14,447) | | | (27,324) | | | (27,678) | | | Equity in earnings of joint ventures | 1,704 | | | 1,395 | | | 3,393 | | | 3,124 | | | Other, net | 1,163 | | | (797) | | | 1,236 | | | (4,927) | | | Income tax expense | (20,074) | | | (18,338) | | | (35,734) | | | (35,152) | | | Net Income | $ | 53,913 | | | $ | 50,523 | | | $ | 99,256 | | | $ | 97,265 | |
(1) Represents business activities related to other miscellaneous revenue streams. (2) Other segment items includes expenses for medical supplies, delivery and packaging, leases, professional services, and other expenses.
|